search button
Open Access

[Corrigendum] Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate

  • Authors:
    • Ioana Macașoi
    • Ioana Zinuca Pavel
    • Alina Elena Moacă
    • Ștefana Avram
    • Vlad Laurențiu David
    • Dorina Coricovac
    • Alexandra Mioc
    • Demetrios A. Spandidos
    • Aristidis Tsatsakis
    • Codruța Șoica
    • Victor Dumitrașcu
    • Cristina Dehelean

  • View Affiliations

  • Published online on: February 18, 2021     https://doi.org/10.3892/or.2021.7981
  • Article Number: 30

  • Copyright : © Macașoi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 44: [Related article:] 1169-1183, 2020; DOI: 10.3892/or.2020.7666

Subsequently to the publication of the above paper, the authors have realized that they should have credited a Professor René Csuk [Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany] for the use of a compound that his group synthesized in the study. Therefore, the authors wish to include the following text in the Acknowledgements section of the Declarations: ‘The authors are grateful to Professor Rene Csuk, Department of Organic Chemistry, Martin-Luther University Halle-Wittenberg, for providing us with the rhodamine B-conjugated oleanolic acid derivative (RhodOA)’. All the named authors agree to this Corrigendum, and apologize to Professor Csuk for the upset and inconvenience caused.

Related Articles

Journal Cover

April-2021
Volume 45 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Macașoi I, Pavel IZ, Moacă AE, Avram Ș, David VL, Coricovac D, Mioc A, Spandidos DA, Tsatsakis A, Șoica C, Șoica C, et al: [Corrigendum] Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate. Oncol Rep 45: 30, 2021.
APA
Macașoi, I., Pavel, I.Z., Moacă, A.E., Avram, Ș., David, V.L., Coricovac, D. ... Dehelean, C. (2021). [Corrigendum] Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate. Oncology Reports, 45, 30. https://doi.org/10.3892/or.2021.7981
MLA
Macașoi, I., Pavel, I. Z., Moacă, A. E., Avram, Ș., David, V. L., Coricovac, D., Mioc, A., Spandidos, D. A., Tsatsakis, A., Șoica, C., Dumitrașcu, V., Dehelean, C."[Corrigendum] Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate". Oncology Reports 45.4 (2021): 30.
Chicago
Macașoi, I., Pavel, I. Z., Moacă, A. E., Avram, Ș., David, V. L., Coricovac, D., Mioc, A., Spandidos, D. A., Tsatsakis, A., Șoica, C., Dumitrașcu, V., Dehelean, C."[Corrigendum] Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate". Oncology Reports 45, no. 4 (2021): 30. https://doi.org/10.3892/or.2021.7981